Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn.
Libraries based on an isolated human immunoglobulin G1 (IgG1) constant domain 2 (CH2) have been previously diversified by random mutagenesis. However, native isolated CH2 is not very stable and the generation of many mutations could lead to an increase in immunogenicity. Recently, we demonstrated th...
Saved in:
| Main Authors: | Rui Gong, Yanping Wang, Tianlei Ying, Dimiter S Dimitrov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0042288&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
by: Thomas Müller, et al.
Published: (2023-12-01) -
Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation
by: Esben Trabjerg, et al.
Published: (2025-06-01) -
The neonatal Fc receptor in cancer FcRn in cancer
by: Diana Cadena Castaneda, et al.
Published: (2020-07-01) -
Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies
by: SuBin Lee, et al.
Published: (2025-07-01) -
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier
by: Julien Lafrance-Vanasse, et al.
Published: (2025-05-01)